Cargando…
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
Regulatory T cells (T reg cells) play a major role in controlling the pathogenic autoimmune process in type 1 diabetes (T1D). Interleukin 2 (IL-2), a cytokine which promotes T reg cell survival and function, may thus have therapeutic efficacy in T1D. We show that 5 d of low-dose IL-2 administration...
Autores principales: | Grinberg-Bleyer, Yenkel, Baeyens, Audrey, You, Sylvaine, Elhage, Rima, Fourcade, Gwladys, Gregoire, Sylvie, Cagnard, Nicolas, Carpentier, Wassila, Tang, Qizhi, Bluestone, Jeffrey, Chatenoud, Lucienne, Klatzmann, David, Salomon, Benoît L., Piaggio, Eliane |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931175/ https://www.ncbi.nlm.nih.gov/pubmed/20679400 http://dx.doi.org/10.1084/jem.20100209 |
Ejemplares similares
-
Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes
por: Baeyens, Audrey, et al.
Publicado: (2013) -
In vivo activation of transferred regulatory T cells specific for third‐party exogenous antigen controls GVH disease in mice
por: Martin, Gaëlle H., et al.
Publicado: (2013) -
NF-κB in Cancer Immunity: Friend or Foe?
por: Lalle, Guilhem, et al.
Publicado: (2021) -
Transcriptional Control of Regulatory T Cells in Cancer: Toward Therapeutic Targeting?
por: Stéphan, Pierre, et al.
Publicado: (2020) -
Fetal Pancreas Transplants Are Dependent on Prolactin for Their Development and Prevent Type 1 Diabetes in Syngeneic but Not Allogeneic Mice
por: Fourcade, Gwladys, et al.
Publicado: (2013)